Nataliya Bulayeva serves as the Laboratory Director at Principle Health Systems, where she brings a wealth of expertise in high-complexity laboratory management and clinical trial design. With a robust background in CLIA, CAP, and COLA regulations, Nataliya is adept at overseeing the complete array of...
Nataliya Bulayeva serves as the Laboratory Director at Principle Health Systems, where she brings a wealth of expertise in high-complexity laboratory management and clinical trial design. With a robust background in CLIA, CAP, and COLA regulations, Nataliya is adept at overseeing the complete array of laboratory operations, ensuring compliance with stringent quality assurance standards. Her role encompasses not only the management of clinical lab operations but also the strategic planning and execution of high-complexity laboratory set-ups, which are critical for advancing diagnostic capabilities and supporting innovative research initiatives.
At Principle Health Systems, Nataliya is currently leading several key projects that focus on the implementation of cutting-edge assays and validation processes. Her technical expertise in LC-MS methods, particularly in toxicology, proteomics, and metabolomics, positions her as a pivotal figure in the development of novel diagnostic tools. Additionally, her proficiency in molecular techniques—including those for COVID-19, urinary tract infections, sexually transmitted infections, and respiratory pathogens—enables her to contribute significantly to public health initiatives and translational research efforts.
Nataliya's skills extend to assay development, fluorescence microscopy, immunohistochemistry, and therapeutic drug monitoring, making her a versatile asset in the laboratory environment. As a project manager and QA specialist, she is committed to fostering a culture of excellence and innovation within her team, ensuring that Principle Health Systems remains at the forefront of laboratory science. Her leadership not only enhances operational efficiency but also drives the successful implementation of clinical trials, ultimately improving patient outcomes and advancing the field of laboratory medicine.
